ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Bonadonna’s Study At Four Years: CMF Group Still Doing Better

November 24, 1978

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 14, 2000

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

Radium Society To Meet In L.A.

March 2, 1979

HHS News: Skin Cancer Awareness Initiative Begun

May 29, 1998